Measuring quality of life in patients with myocardial infarction or stroke : a feasibility study of four questionnaires in The Netherlands.
To test in patients with a history of myocardial infarction or stroke the feasibility of four quality of life measurements - the Nottingham health profile (NHP), the heart patients psychological questionnaire (HPPQ), the sickness impact profile (SIP), and the hospital anxiety and depression scale (HAD).
Subjects were tested and retested after an interval of 14 days : questionnaires were self assessed.
Participants were randomly selected from the Rotterdam stroke data bank (stroke patients ; n=16, mean (SD) age 66.0 (11.0) years and from the population based Rotterdam study (myocardial infarction ; n=20, mean (SD) age 72.7 (7.9) years, controls ; n=17, mean (SD) age 72.8 (7.3) years.
Measurements and main results
Mean (SD) administration times for the NHP, HPPQ, SIP, and HAD were 7.9 (3.5), 10.5 (4.3), 21.0 (9.8), and 5.5 (2.8) minutes respectively.
On average, the test-retest reliability was good, with Spearman correlations ranging from 0.31 to 0.95.
For instance, median SIP total scores for myocardial infarction and stroke patients were 12.4 (interquartile range 7.0-19.1) and 11.4 (5.9-15.4) respectively, compared with 7.7 (3.7-11.3) in the control group (p values of 0.04 and 0.14 respectively).
This study suggests that use of the four instruments tested may be feasible and reliable for assessing aspects of quality of life in patients with a history of a myocardial infarction or stroke.
Mots-clés Pascal : Infarctus, Myocarde, Accident cérébrovasculaire, Homme, Qualité vie, Méthode étude, Questionnaire, Psychométrie, Validation test, Fidélité test, Pays Bas, Europe, Système nerveux pathologie, Système nerveux central pathologie, Encéphale pathologie, Cérébrovasculaire pathologie, Appareil circulatoire pathologie, Vaisseau sanguin pathologie
Mots-clés Pascal anglais : Infarct, Myocardium, Stroke, Human, Quality of life, Investigation method, Questionnaire, Psychometrics, Test validation, Test reliability, Netherlands, Europe, Nervous system diseases, Central nervous system disease, Cerebral disorder, Cerebrovascular disease, Cardiovascular disease, Vascular disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0555904
Code Inist : 002B12A03. Création : 01/03/1996.